{
    "id": 31586,
    "fullName": "EPHB6 Q926R",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "EPHB6 Q926R lies within the cytoplasmic domain of the Ephb6 protein (UniProt.org). Q926R confers a gain of function to the Ephb6 protein as it results in increased interaction with Epha2 leading to the activation of Epha2/Jnk/RhoA signaling, and increased activation of RhoA, Fak phosphorylation, formation of focal adhesion, cell adhesion, migration, and proliferation in cultured cells (PMID: 31160603).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 16736,
                    "pubMedId": 31160603,
                    "title": "EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31160603"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2051,
        "geneSymbol": "EPHB6",
        "terms": [
            "EPHB6",
            "HEP"
        ]
    },
    "variant": "Q926R",
    "createDate": "11/14/2019",
    "updateDate": "02/18/2020",
    "referenceTranscriptCoordinates": {
        "id": 185527,
        "transcript": "XM_011515881",
        "gDna": "chr7:g.142870383A>G",
        "cDna": "c.2777A>G",
        "protein": "p.Q926R",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 19218,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, addition of Y27632 restored sensitivity to Taxol (paclitaxel) in cells expressing EPHB6 Q926R, and inhibited colony formation in culture (PMID: 31160603).",
            "molecularProfile": {
                "id": 33957,
                "profileName": "EPHB6 Q926R"
            },
            "therapy": {
                "id": 8939,
                "therapyName": "Paclitaxel + Y27632",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 16736,
                    "pubMedId": 31160603,
                    "title": "EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31160603"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19224,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, addition of Y15 restored sensitivity to Taxol (paclitaxel) in cells expressing EPHB6 Q926R, and inhibited colony formation in culture (PMID: 31160603).",
            "molecularProfile": {
                "id": 33957,
                "profileName": "EPHB6 Q926R"
            },
            "therapy": {
                "id": 8942,
                "therapyName": "Paclitaxel + Y15",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 16736,
                    "pubMedId": 31160603,
                    "title": "EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31160603"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19220,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, ALW-II-41-27 treatment inhibited adhesion of cancer cells expressing EPHB6 Q926R in culture (PMID: 31160603).",
            "molecularProfile": {
                "id": 33957,
                "profileName": "EPHB6 Q926R"
            },
            "therapy": {
                "id": 3274,
                "therapyName": "ALW-II-41-27",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 16736,
                    "pubMedId": 31160603,
                    "title": "EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31160603"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19214,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, addition of ALW-II-41-27 restored sensitivity to Taxol (paclitaxel) in cells expressing EPHB6 Q926R, and inhibited colony formation in culture (PMID: 31160603).",
            "molecularProfile": {
                "id": 33957,
                "profileName": "EPHB6 Q926R"
            },
            "therapy": {
                "id": 8940,
                "therapyName": "ALW-II-41-27 + Paclitaxel",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 16736,
                    "pubMedId": 31160603,
                    "title": "EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31160603"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19215,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, addition of SP600125 restored sensitivity to Taxol (paclitaxel) in cells expressing EPHB6 Q926R, and inhibited colony formation in culture (PMID: 31160603).",
            "molecularProfile": {
                "id": 33957,
                "profileName": "EPHB6 Q926R"
            },
            "therapy": {
                "id": 8941,
                "therapyName": "Paclitaxel + SP600125",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 16736,
                    "pubMedId": 31160603,
                    "title": "EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31160603"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19222,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Y27632 treatment inhibited adhesion of cancer cells expressing EPHB6 Q926R in culture (PMID: 31160603).",
            "molecularProfile": {
                "id": 33957,
                "profileName": "EPHB6 Q926R"
            },
            "therapy": {
                "id": 8938,
                "therapyName": "Y27632",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 16736,
                    "pubMedId": 31160603,
                    "title": "EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31160603"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19223,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Y15 treatment inhibited adhesion of cancer cells expressing EPHB6 Q926R in culture (PMID: 31160603).",
            "molecularProfile": {
                "id": 33957,
                "profileName": "EPHB6 Q926R"
            },
            "therapy": {
                "id": 2088,
                "therapyName": "Y15",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 16736,
                    "pubMedId": 31160603,
                    "title": "EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31160603"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19221,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, SP600125 treatment inhibited adhesion of cancer cells expressing EPHB6 Q926R in culture (PMID: 31160603).",
            "molecularProfile": {
                "id": 33957,
                "profileName": "EPHB6 Q926R"
            },
            "therapy": {
                "id": 3366,
                "therapyName": "SP600125",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 16736,
                    "pubMedId": 31160603,
                    "title": "EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31160603"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 33957,
            "profileName": "EPHB6 Q926R",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 33958,
            "profileName": "CDH11 dec exp EPHB6 Q926R",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 185527,
            "transcript": "XM_011515881",
            "gDna": "chr7:g.142870383A>G",
            "cDna": "c.2777A>G",
            "protein": "p.Q926R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 185528,
            "transcript": "XM_011515881",
            "gDna": "chr7:g.142870383A>G",
            "cDna": "c.2777A>G",
            "protein": "p.Q926R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}